post implant

post im·plant

that portion of a dental implant substructure that protrudes through the mucosa to connect with the restoration.

post im·plant

(pōst implant)
Portion of a dental implant substructure that protrudes through mucosa to connect with restoration.
References in periodicals archive ?
4 percent for patients at six months post implant, as assessed by the Unified Parkinson's Disease Rating Scale Part III, when compared to baseline.
Leonardo CalE from the Polyclinic Casilino, Rome, Italy, reports, Patients feel more comfortable post implant.
There is an increased risk for major vascular complications and for stroke during the first month post implant.
Each patient receiving the HeartWare VAS or control LVAD will be followed to the primary endpoint at two years, with a subsequent follow-up period extending to five years post implant.
The 65 year patient had experienced a recurrence of regurgitation after 6 months post implant.
And at 4 years post implant, more than 50% of the patients had at least a 50% reduction in seizure frequency.
Additionally, GORE VIABIL Biliary Endoprosthesis is licensed in Canada for the treatment of benign and malignant biliary strictures and can be removed from such strictures for up to one-year post implant.
Fast absorbing (weeks), medium absorbing (months), and a long last (closer to a half year)] Unlike traditional plastic biliary stents that are used hundreds of thousands of times per year and have to be removed and/or exchanged routinely to relieve the Archimedes device can be used and implanted using the exact techniques applied with the existing technology with the added benefit of allowing the bile to flow on the outside of the devices as well as through the center helping to minimize the potential for post implant obstruction while eliminating the cost and risk associated with the removal procedures.
Two years post implant, 55 percent of patients experienced a 50 percent or greater reduction in seizures.
Only two adverse events were more frequent during active treatment: nausea, which occurred 1-2 days post implant in 33% of patients when being treated with afamelanotide, compared with 18% of patients when being treated with placebo; and hot flushes, which were noted 1-2 days after afamelanotide implantation in 11% of patients, compared with just 1% with placebo.
EFFORTLESS will follow the S-ICD System in 1,000 patients for a period of 60 months post implant.
2 at three months post implant (in the patients who have reached the three-month follow up, n=113)